These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 27489287)

  • 1. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
    Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
    Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer.
    Shachar SS; Deal AM; Weinberg M; Williams GR; Nyrop KA; Popuri K; Choi SK; Muss HB
    Clin Cancer Res; 2017 Jul; 23(14):3537-3543. PubMed ID: 28143874
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
    Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
    Staley SA; Tucker K; Newton M; Ertel M; Oldan J; Doherty I; West L; Zhang Y; Gehrig PA
    Gynecol Oncol; 2020 Mar; 156(3):695-700. PubMed ID: 31928805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer.
    Aleixo GFP; Shachar SS; Deal AM; Nyrop KA; Muss HB; Chen YT; Yu H; Williams GR
    Breast Cancer Res Treat; 2020 Aug; 182(3):631-642. PubMed ID: 32519169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy.
    Rier HN; Jager A; Sleijfer S; van Rosmalen J; Kock MCJM; Levin MD
    Breast; 2017 Feb; 31():9-15. PubMed ID: 27810702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
    Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
    [No Abstract]   [Full Text] [Related]  

  • 11. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
    Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
    Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
    Weinberg MS; Shachar SS; Muss HB; Deal AM; Popuri K; Yu H; Nyrop KA; Alston SM; Williams GR
    Breast J; 2018 May; 24(3):278-284. PubMed ID: 29139618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?
    Williams GR; Deal AM; Muss HB; Weinberg MS; Sanoff HK; Nyrop KA; Pergolotti M; Shachar SS
    Oncotarget; 2017 May; 8(20):33658-33665. PubMed ID: 28431396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of computed tomography images as a prognostic marker in critically ill cancer patients.
    Toledo DO; Carvalho AM; Oliveira AMRR; Toloi JM; Silva AC; Francisco de Mattos Farah J; Prado CM; Silva JM
    Clin Nutr ESPEN; 2018 Jun; 25():114-120. PubMed ID: 29779805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy.
    Guo J; Cai P; Li P; Cao C; Zhou J; Dong L; Yang Y; Xuan Q; Wang J; Zhang Q
    Curr Oncol; 2021 Mar; 28(2):1325-1337. PubMed ID: 33806839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy.
    Ueno A; Yamaguchi K; Sudo M; Imai S
    Support Care Cancer; 2020 Sep; 28(9):4249-4254. PubMed ID: 31900607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.
    Bamba S; Sasaki M; Takaoka A; Takahashi K; Imaeda H; Nishida A; Inatomi O; Sugimoto M; Andoh A
    PLoS One; 2017; 12(6):e0180036. PubMed ID: 28644887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
    Prado CM; Baracos VE; McCargar LJ; Reiman T; Mourtzakis M; Tonkin K; Mackey JR; Koski S; Pituskin E; Sawyer MB
    Clin Cancer Res; 2009 Apr; 15(8):2920-6. PubMed ID: 19351764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.